ADMA Biologics' revenue growth has plateaued over the last three quarters, raising concerns about near-term momentum. See why ...

Hikma Pharmaceuticals PLC closed 9.83% below its 52-week high of £23.60, which the company reached on February 13th.

In this article, we are going to take a look at where ADMA Biologics, Inc. (NASDAQ:ADMA) stands against the other stocks. The stock market kicked off the trading week on a mixed note, with two ...

The latest trading session saw Adma Biologics (ADMA) ending at $16.47, denoting a +1.92% adjustment from its last day's close. This move outpaced the S&P 500's daily gain of 0.61%. Elsewhere ...

Is Adma Biologics (ADMA) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out. Adma Biologics is a member of our Medical group, which ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ADMA Biologics (ADMA – Research Report) and Crinetics Pharmaceuticals (CRNX – Research Report ...

Adma Biologics (ADMA ... The results are expected to be released on May 12. This pharmaceutical and medical device company is expected to post quarterly loss of $0.23 per share in its upcoming ...

Yesterday, the court heard that Holmes did it once more, sending reports that prominently featured the logo of Schering-Plough, the large pharmaceutical company that was acquired by Merck in 2009.

SAN JOSE, Calif.— A former scientist for Pfizer Inc.PFE1.47%increase; green up pointing triangle testified in federal court Friday that he had advised his employer against working with Theranos ...

ADMA Biologics bought its contract manufacturer ... A warning letter issued to its CDMO, Biotest Pharmaceuticals, followed in 2014. When the partners couldn’t get the issues quickly resolved ...